PTH PDUFA 4/30/23 expectations?

[anonymous]

Ascendis’ PDUFA date of April 30, 2023 with respect the NDA Ascendis submitted in August 2022, (ii) the FDA’s indication that it is currently not planning to hold an Advisory Committee Meeting with respect the NDA Ascendis submitted in August 2022

 

[anonymous]

Wait for the insanity to come out...

 

[anonymous]

What do you mean?

 

[anonymous]

What’s the deal with this product? Are they still interviewing? What’s taking so long to hear back? Is this place a mess??

 

[anonymous]

What’s the deal with this product? Are they still interviewing? What’s taking so long to hear back? Is this place a mess??

It’s a Novo redo.

 

[anonymous]

It’s a Novo redo.

No lie. Talk about a bunch of “leaders” playing outside their league….

 

[anonymous]

No lie. Talk about a bunch of “leaders” playing outside their league….

"Albert the midget" leading this sales force will have his sales results be just like him... short of goal.

 

[anonymous]

It’s a Novo redo.

y. With Joe Kelly and John Spera leading the charge, it is a Novo re-do. So yes, a total hot mess.

 

[anonymous]

"Albert the midget" leading this sales force will have his sales results be just like him... short of goal.

I interviewed with him and was not impressed. Thankfully I was not offered a job I had decided I didn’t want after meeting him and Dan—WTF!!!

 

[anonymous]

I interviewed with him and was not impressed. Thankfully I was not offered a job I had decided I didn’t want after meeting him and Dan—WTF!!!

he is an ass wipe. you have to be pretty bad to be named on CP and everyone is aware of his deficiencies. the only thing he is suited to do is work in pharma, he has zero intelligence and zero talent, that's why he works here. shit hole company with shit hole leadership.

 

[anonymous]

How's that PTH approval going? Still don't know what the FDA has an issue with? Time for Skytrofa to crash and burn now that Sogroya has the market covered. Don't try interviewing with Novo when the house falls down around you.

 

[anonymous]

You complainers are so clueless!

Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $152.00

 

[anonymous]

You complainers are so clueless!

Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $152.00

ASND down 42% YTD… yup, we are the ones that are clueless. Sling your BS somewhere else - we know better.

 

[anonymous]

You complainers are so clueless!

Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $152.00

And I want a penthouse suite on Mars- doesn't mean it's reasonable or actually achievable. Actual price compared to estimated are very different. Just shows how you are all clueless, but then again, nothing but Novo rejects at Ass-cendis.

 

[anonymous]

You complainers are so clueless!

Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $152.00

And the market see right through the Ascendis lies. When all is said and done your so called leaders will enjoy a nice parachute out for misleading investors. Earnings come out, seems like good news, stock plummets…..again. PTH will receive a CRL and the only reasons GH sales went up is because HCPs had no choice, several GH products were out of stock. Now Novo will have a weekly, with managed care AND a device like their daily, meaning much easier then the junk Ascendis is pushing out. I see a huge drop in GH sales including the loss of existing patients. After the CRL for PTH I guess the job postings will dry up.

 

[anonymous]

"Albert the midget" leading this sales force will have his sales results be just like him... short of goal.

man this is hilarious and so true lol

 

[anonymous]

And the market see right through the Ascendis lies. When all is said and done your so called leaders will enjoy a nice parachute out for misleading investors. Earnings come out, seems like good news, stock plummets…..again. PTH will receive a CRL and the only reasons GH sales went up is because HCPs had no choice, several GH products were out of stock. Now Novo will have a weekly, with managed care AND a device like their daily, meaning much easier then the junk Ascendis is pushing out. I see a huge drop in GH sales including the loss of existing patients. After the CRL for PTH I guess the job postings will dry up.

Who cares. This place is thick with married ladies who like to party!

 

[anonymous]

Who cares. This place is thick with married ladies who like to party!

You must be desperate.

 

[anonymous]

You must be desperate.

Im here aren’t I?

 

[anonymous]

Im here aren’t I?

Touché. I spoke to a recruiter last week and when I told them I was with Ascendis she said “I’ve been getting a lot of people calling from over there”